Topics in Pharmaceutical Regulation
This session will explore multiple topics on the subject of pharmaceutical regulation. One paper will discuss the relationship between expedited approval programs and post-market safety events. A second paper will use FDA designations to construct an index to measure pharmaceutical innovation. The final paper presents a case for the efficacy standard in FDA approvals.